Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocarnitine for prevention of intradialytic hypotension in chronic kidney disease on hemodialysis
ACTRN12616000660482Phase 3Completed
- Sponsor
- Unidad de Hemodialisis del Hospital Universitario Dr. Jose Eleuterio Gonzalez
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levocarnitine in chronic kidney disease (CKD) (4 arms), sponsored by Unidad de Hemodialisis del Hospital Universitario Dr. Jose Eleuterio Gonzalez. Primary endpoint: Number of episodes of intradialytic hypotension. Started Apr 2016; status: completed.
02
Drugs
levocarnitine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12616000660482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000660482.